OVERVIEW
Authorship / Contributorship, Conflicting & Competing Interests, Duplicate Publication, Informed Patient Consent, Machine Learning Tools, Peer Reviewer Confidentiality, Permissions, Responsible Conduct of Research
Case Series, Conflict of Interest Statement, Copyright Transfer, Double Blinding, Funding Statement, ICMJE Guidelines, Length, Meta-Analyses, NIH-Funded Research, Randomized Controlled Trials, Research Reports, Review Articles
MANUSCRIPT CONTENT & ORGANIZATION:
Formatting & Style, Title Page, Abstract, Body of Manuscript, References, Tables, Figures & Illustrations
Access to Editorial Manager, File Upload & Accepted File Types, Peer Review
AIMS AND SCOPE
JABFM publishes original material from authors with new knowledge to contribute to the understanding and advancement of family medicine research and clinical practice. JABFM also serves as an important forum for the specialty of family medicine, and as a source of news from the ABFM.
- JABFM publishes online only, with six bimonthly issues per year.
- There is no charge to submit or publish with the Journal. The Journal of the American Board of Family Medicine is funded by the American Board of Family Medicine.
- Online guest accesses average: 305,000 hits per month in 2024.
- Impact factor for 2023: 2.4; 2024: 2.6
- JABFM Diversity Statement.
FEATURES

EDITORIAL POLICIES
The JABFM adheres to the authorship criteria outlined in the ICMJE Recommendations.
Each author should meet all the of the following four criteria:
- Substantial contributions to the conception and design, acquisition, or analysis and interpretation of data.
- Drafting the paper or revising it critically for important intellectual content.
- Final approval of the version to be published.
- All authors should take public responsibility for their manuscripts.
Corresponding authors will be identified as such in the published article and:
- Must be willing to submit the actual data for editorial review with the manuscript, if asked by the editor.
- Should be prepared to explain the order of the author names and their contributions, if asked by the editor.
Contributors should be named in the Acknowledgments, noting what they did; for example, leading organizations, acquiring funding, collecting data, contributing patients, preparing the manuscript, etc.
Authors of papers from research groups, practice-based research networks, or multi-site collaborations should see: Flanagin A, Fontanarosa PB, DeAngelis CD. Authorship for research groups. JAMA, 2002; 288 (24): 3166-3168.
JABFM does not allow machine learning tools such as ChatGPT to be listed as authors. Further, if any such tool is used to generate drafts of the submitted manuscript, this must be explicitly stated as a disclosure. These tools use previously written text and do a poor job of adding appropriate citations. Using someone else’s text without attribution is plagiarism, whether intentional or not. All human authors of manuscripts that are written with the assistance of a machine learning tool are responsible for ensuring that any ideas or text taken from previously published work are appropriately and accurately cited.
Conflicting & Competing Interests
JABFM adheres to policies that increase disclosure and transparency related to competing interests or conflicts of interest, including:
- ICMJE Recommendations.
- DeAngelis CD, Fontanarosa PB, Flanagin A. Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA, 2001; 286 (1): 89-91.
JABFM expects authors to disclose any commercial associations that pose, or have the appearance of posing, a conflict of interest in connection with the submitted article, including but not limited to: employment, consultancies, stock ownership or other equity interests, patent-licensing arrangements, honoraria, paid expert testimony, personal relationships, academic competition, and intellectual passion.
Any potential conflicts of interest or competing interests must be disclosed upon submission. This applies to all types of manuscripts, including letters to the editor. Failure to include this information will delay the manuscript at check-in.
Manuscripts are considered only if they have not been previously published in print or electronic format, and with the understanding that they are not under consideration elsewhere. If there is any doubt about what might constitute duplicate publication, authors should include with their submission copies of possibly duplicative materials that have been previously published, or that are under consideration elsewhere. Authors should avoid self-plagiarism. This restriction does not apply to abstracts or press reports published in connection with scientific meetings. Authors are responsible to ensure that preprints of the papers are amended to refer readers to the location of, and appropriate reference for, the final peer-reviewed published article. An electronic link to the JABFM on-line version is preferred. Exceptions for unusual circumstances will be considered on a case-by-case basis.
Patients and research participants must give full, informed consent to participate in research studies, case studies, and other projects leading to publication. All case reports submitted must have a signed Patient Consent Form for each patient mentioned in order for the JABFM to review the manuscript.
The JABFM will also accept a signed, patient consent form from the authors' institution as a substitution. Please upload any patient consent forms as appendices to your manuscript submission. The editorial office will remove them before peer review.
Peer reviewers agree to treat all information in manuscripts as confidential and must disclose any real or perceived competing interests or conflicts of interest before accepting a request.
Materials taken from other sources must be accompanied by a written statement from the publisher (and in some instances, the original authors) giving JABFM permission for reproduction. It is the submitting authors' responsibility to pay for any fees associated with copyright permissions.
Responsible Conduct of Research
Authors must indicate that Institutional Review Board approval was obtained for the research protocol. JABFM adheres to the ICMJE Recommendations on the Protection of Research Participants.
MANUSCRIPT PREPARATION
Case series are preferred over the report of a single patient. All descriptions of patients require written consent. Please refer to the Informed Patient Consent section.
For guidance in preparing a case series, refer to: McCarthy et al. How to write a case report. Fam Med, 2000; 32 (3): 190-195.
Upon acceptance, transfer of copyright to the JABFM is required of all authors of the manuscript. Accepted manuscripts will not enter the production stage until all authors have submitted a signed Copyright Transfer Form. The form will be made available to the corresponding author at the time of acceptance. The JABFM recognizes that US government employees are exempt from signing copright forms. In this case, the editorial office will ask the corresponding author to list those authors, in a Word document, who cannot sign a Copyright Transfer Form.
JABFM prefers to blind peer reviewers to the names of authors, while recognizing that this is not always completely possible. You will be asked to submit your title page(s) as a separate file. Authors should consider, where feasible, removing other obvious references to authors' names in the body of the manuscript. All identifying information should be placed only on the title page as it will be removed before the peer review process.
Authors should adhere to guidelines of the International Committee of Medical Journal Editors (ICMJE) in the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals
The title page should include a funding statement. Funding statements should include all sources of funding or financial support, direct or indirect and regardless of size, for all authors. If there were no sources of funding, please so state. Failure to include this information will delay the manuscript at check-in. Authors will also be required to supply this information when submitting the manuscript electronically.
Conflict of Interest Statement
The title page should also include a conflict of interest statement. Any potential conflicts of interest or competing interests must be disclosed upon submission. This applies to all types of manuscripts, including letters to the editor. If there are no conflicts, please so state.

*Please note that the suggested lengths by section type are guidelines based on recent publication averages. The Journal is flexible with these counts, within reason.
Meta-analyses should follow the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Statement.
National Institutes of Health (NIH)-Funded Research
The JABFM recognizes that as of April 7, 2008, all peer-reviewed publications reporting findings from studies funded by the NIH must be submitted to PubMed Central, the NIH's free digital archive of biomedical and life sciences journal literature in the United States. Per the NIH Public Access Policy, such NIH-funded publications must be made available no later than 12 months after the official date of publication.
As a courtesy to our authors, beginning with the January 2025 issue, all published manuscripts in the JABFM will be submitted to PubMed Central.
Randomized controlled trials should be organized according to CONSORT (Consolidated Standards of Reporting Trials) Guidelines. Please also see:
- Piaggio et al. Reporting of Noninferiority and Equivalence Randomized Trials: An Extension of the CONSORT Statement. JAMA, 2006;295:1152-1160.
- Chan A-W, et al. SPIRIT 2025 Statement. Updated Guideline for Protocols of Randomized Trial. JAMA, 2025.
Research reports should be organized using ICJME's IMRAD (Introduction, Methods, Results and Discussion) Format.
The CRISP guidelines for reporting primary care research are also available for use by authors. Please see both the CRISP Website and CRISP Checklist.
Review articles should use SORT (Strength of Recommendation Taxonomy) to grade diagnostic and treatment recommendations.
MANUSCRIPT CONTENT & ORGANIZATION
In order to facilitate double-blinding during the peer review process, we ask that the title page be submitted in a separate file; this is required when submitting through the manuscript submission system, Editorial Manager. Editorial Manager will automatically blind the title page for peer reviewers. The title page is the only file that should have identifying information.
Title page file(s) must contain:
- Title
- Author names and affiliations
- Conflicting and Competing Interests
- Funding Statement
- Acknowledgements (for all contributors, except authors)
- Word count
- Keywords (Please use the National Library of Medicine's Medical Subject Headings (MESH) 2025) to determine keywords.
- MS Word File only; PDFs are not accepted.
- The word count for the abstract is separate from that of the body of the paper. Abstracts should be 200 - 250(max) words.
- Whenever possible, the abstract should have a structured format, using section headers appropriate to the text, such as background or introduction, methods, results, discussion, conclusions, etc.
- All research articles and commentaries should include abstracts, which allows indexing services to better discover JABFM articles. If a structured abstract does not apply to your paper, the JABFM will also accept an unstructured abstract.
- MS Word File only; PDFs are not accepted.
- The body of the manuscript, submitted in a separate file from the title page, should begin with only the title of the manuscript on the first page. The second page should then start with the body of the manuscript.
- Authors should also consider removing other obvious references to author names in the body of the manuscript, where feasible.
- For revised manuscripts, changes between the two most recent versions should be underlined. A marked-up version of the manuscript may also be uploaded.
- Please turn on the continuous line number feature in the Word document under the 'layout' tab, so that our editors and peer reviewers can identify and comment on specific lines in your manuscript.
- MS Word File only; PDFs are not accepted.
- The JABFM uses the American Medical Association (AMA) Manual of Style.
- The reference list should not include manuscripts in preparation, manuscripts submitted for publication but not yet accepted, observations, or personal communications. References to unpublished material may include material accepted for publication but not yet published (e.g. in press), and presentations made at scientific or professional meetings.
- List all authors when there are 6 or fewer; when there are 7 or more, list the first 3, then et al. For examples refer to: American Medical Association Manual of Style: A Guide for Authors and Editors (11th Edition) and ICMJE Recommendations for Manuscripts Submitted to Biomedical Journals.
- References should be double-spaced using in-line numerals, and should start on a separate page.
- Use superscripts or in-line parentheses in the body of the manuscript to indicate references.
- References first cited in tables or figure legends must be numbered so that they are in sequence with references cited in the text.
- Authors are responsible for checking the accuracy of their reference citations.
- MS Word File only; PDFs are not accepted.
JABFM follows AMA style for tables. The AMA style guide may be consulted for detail beyond these notes:
- Please use Microsoft Word's table feature. Excel files may not be submitted, although the cells may be copied and pasted into Word.
- Excessive tabular data are discouraged.
- Auto-formatting, text boxes, graphics boxes, and drawings may prevent file conversion and should not be used.
- Tables should appear at the end of the manuscript, double spaced and placed on separate sheets. Insert in the body of the manuscript a bracketed note as to the approximate placement of each table; e.g., [Insert Table 1].
- Table titles, labels, and explanatory notes should have sufficient detail to permit interpretation without referring to the text.
- Footnotes should use the following symbols, in this sequence: * (asterisk), ±(dagger), ± (double dagger), ± (section mark), || (parallel mark), ± (paragraph symbol), # (number sign), ** (asterisk, repeated), ±± (dagger, repeated), ±± (double dagger, repeated), etc.
- All abbreviations should be defined in the footnotes for each table.
- If the table is adapted from another source, it is the authors' responsibility to request permission to adapt the table and pay any royalties/fees. The editorial office will ask for this documentation if the manuscript is accepted.
- Acceptable file types for figures include: JPEG, TIFF, EPS, and PDF. Figures and illustrations should be high resolution and professional quality.
- Each figure should be uploaded as a seperate file.
- Symbols, lettering, and numbering should be clear, and these elements should be large enough to remain legible after the figure has been reduced.
- Figures should have legends descriptive enough to permit interpretation without referring to the text. Submit figure legends on a separate page.
- Figure titles, labels, and explanatory notes should have sufficient detail to permit interpretation without referring to the text.
- All abbreviations should be defined in the footnotes for each figure.
- Once a manuscript is accepted for publication, authors must provide separate files for all illustrations and figures (including charts and graphs) in high-quality, camera-ready, reproducible form. JABFM strongly encourages authors to submit figures in separate digital files at the outset. However, if necessary, for review purposes figures may be embedded in the manuscript, after the tables.
- Original photos or artwork in hard copy are not accepted.
- If the figure is adapted from another source, it is the authors' responsibility to request permission to adapt the figure and pay any royalties/fees. The editorial office will ask for this documentation if the manuscript is accepted.
- Manuscripts should be double spaced throughout, including references.
- Page numbers should appear on all pages.
- Please use line numbers in the body of the manuscript. This will make it easier for reviewers to identify particular areas of your manuscript. This function can be turned on in the Word document.
- Word (or similar word-processing) files are best for submission. PDFs will not be accepted.
- Auto-formatting, text boxes, graphics boxes, or drawings may prevent file conversion and should not be used in the body of the manuscript.
- Abbreviations are discouraged, except for units of measurement. The first time an abbreviation appears, it should be in parentheses after the words for which it stands.
- Generic names of drugs should be used, rather than brand names.
- Gender bias should be avoided and gender-inclusive language used whenever possible.
- Use the most precise definition, as possible, of who you are talking about, (i.e. use physicians when talking about physicians). When the group is mixed, define who is all included (i.e. physicians, PAs, NPs, nurses, etc.) The JABFM prefers 'clinician' over the term 'provider'.
- Footnotes in the body of the manuscript are not accepted.
- Table and figure titles need to include detailed, descriptive information on the sample and time/context of data collection, when possible.
- For revised manuscripts, changes between the two most recent versions should be underlined. A marked-up version of the manuscript may also be uploaded.
MANUSCRIPT SUBMISSION
Access to Editorial Manager (EM)
The Editorial Manager (EM) online system may be accessed on the JABFM home page. To create a new author account, please following the following steps:
- Access EM via our website or directly through the Editorial Manager Author Portal.
- Click on author portal in the center area of our home page.
- If you're a first-time user, you will need to create an author account, where you will choose a User Name and Password.
- Insert your User Name and Password. These are case-sensitive.
- If you have difficulty accessing EM, it may be the result your firewall or pop-up blocker settings.
File Upload and Accepted File Types
You will be asked to submit your files in the following order (MS Word is the only accepted file type for the title page, abstract, and manuscript/references):
- Title page (Required - MS Word file only)
- Abstract (Required for most submissions - MS Word file only)
- Manuscript and References (Required - Please use page numbers and line numbers; MS Word file only)
- Tables (Optional - No Excel files accepted; however, they can be pasted into a Word file)
- Figures (Optional - Each figure must be uploaded separately; acceptable files include: JPEG, TIFF, EPS, PDF)
- Appendices (Optional - All file types mentioned above are accepted)
- IMPORTANT NOTE: Please DO NOT upload a cover letter (for blinding purposes). There is a section in the online submission form to type (or copy and paste) your correspondence to the editor.
The following information is required when submitting through the Editorial Manager Author Portal and should be handy:
- Abstract
- Funding statement
- Conflict of interest statement
- Classifications / Keywords
- Recommendation of 2 peer reviewers:
- Peer reviewers do not have to be agreeable at the point of submission. The editorial office will handle the recruiting and invitation process if an additional reviewer is needed for your manuscript.
- These recommendations can be those who are experts in the field of your manuscript and should be without conflicts of interest to any of the authors.
- Most authors find these suggested reviewers in the literature, i.e. the manuscript’s references and/or PubMed, where most corresponding author information can be found, including email addresses.
- Response to reviewers (for revised manuscripts; please use page and line numbers for each comment)
The peer review process takes approximately 60-90 days, depending upon peer reviewer availability and the subject matter of the submission. We strive to keep your manuscript the least amount of time possible, while still providing a thorough and thoughtful review.
FORMS
Patient Consent Form (For Case Reports)
- JABFM Patient Consent Form
- We will also accept a signed, patient consent form from the authors' institution as a substitution. Please upload any patient consent forms as appendices to your manuscript submission. The editorial office will remove them before peer review.
Copyright Transfer Agreements (CTAs)
Copyright Transfer Agreement (CTA) link access will be made available after acceptance of the manuscript. If you currently have an accept manuscript with us and are in need of the copyright form, please email the editorial office: jabfm@augusta.edu with your manuscript number.
QUESTIONS?

